Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder

被引:130
作者
Hoehn-Saric, R
Schlund, MW
Wong, SHY
机构
[1] Johns Hopkins Univ, Johns Hopkins Hosp, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA
[2] Kennedy Inst, Dept Behav Psychol, Baltimore, MD 21205 USA
[3] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
关键词
functional magnetic resonance imaging; worry; anxiety; SSRI;
D O I
10.1016/j.pscychresns.2004.02.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of auditory statements describing a personal worry on brain activation as measured by functional magnetic resonance imaging were examined in patients with generalized anxiety disorder (GAD) before and after anxiety reduction with citalopram. Six patients were imaged while listening to verbal descriptions of a personal worry or a neutral statement before treatment with citalopram and after 7 weeks of treatment. Pre-post drug analyses showed treatment with citalopram reduced self-reported anxiety and reduced BOLD responses to a pathology-specific worry and a neutral stimulus. After treatment, worry sentences, compared to neutral statements, elicit reduced BOLD responses in prefrontal regions, the striatum, insula and paralimbic regions. In addition, contrasts before and after treatment revealed reductions in the differential response that existed between worry and neutral statements. Overall reduction of BOLD response was most prominent during neutral statements, particularly in the left hemisphere. These findings support the clinical impression that GAD patients overreact to both pathology-specific and non-specific cues and that the reduction of anxiety attenuates the response to both types of cues. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 43 条
[1]
Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder - Twenty-four-week placebo-controlled dose-ranging study [J].
Allgulander, C ;
Hackett, D ;
Salinas, E .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 :15-22
[2]
Barlow D.H., 2002, Anxiety and its disorders: The nature and treatment of anxiety and panic, V2nd
[3]
THE EFFECT OF WORRY ON CARDIOVASCULAR-RESPONSE TO PHOBIC IMAGERY [J].
BORKOVEC, TD ;
HU, S .
BEHAVIOUR RESEARCH AND THERAPY, 1990, 28 (01) :69-73
[4]
Worry:: A cognitive phenomenon intimately linked to affective, physiological, and interpersonal behavioral processes [J].
Borkovec, TD ;
Ray, WJ ;
Stöber, J .
COGNITIVE THERAPY AND RESEARCH, 1998, 22 (06) :561-576
[5]
POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF EFFECTS OF BENZODIAZEPINES ON REGIONAL GLUCOSE METABOLIC-RATE IN PATIENTS WITH ANXIETY DISORDER [J].
BUCHSBAUM, MS ;
WU, J ;
HAIER, R ;
HAZLETT, E ;
BALL, R ;
KATZ, M ;
SOKOLSKI, K ;
LAGUNASSOLAR, M ;
LANGER, D .
LIFE SCIENCES, 1987, 40 (25) :2393-2400
[6]
Attention-related activity during episodic memory retrieval: a cross-function fMRI study [J].
Cabeza, R ;
Dolcos, F ;
Prince, SE ;
Rice, HJ ;
Weissman, DH ;
Nyberg, L .
NEUROPSYCHOLOGIA, 2003, 41 (03) :390-399
[7]
WORRY - AN ELECTROCORTICAL ANALYSIS [J].
CARTER, WR ;
JOHNSON, MC ;
BORKOVEC, TD .
ADVANCES IN BEHAVIOUR RESEARCH AND THERAPY, 1986, 8 (04) :193-204
[8]
The extended amygdala: Are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? [J].
Davis, M ;
Shi, CJ .
ADVANCING FROM THE VENTRAL STRIATUM TO THE EXTENDED AMYGDALA: IMPLICATIONS FOR NEUROPSYCHIATRY AND DRUG ABUSE: IN HONOR OF LENNART HEIMER, 1999, 877 :281-291
[9]
First MB, 1997, Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)
[10]
Friston K.J., 1994, Human Brain Mapping, V2, P189, DOI DOI 10.1002/HBM.460020402